Related Experiment Video
Updated: Jun 22, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Drug repurposing for cancer
Juni Banerjee1, Anand Krishna Tiwari1, Shuvomoy Banerjee1
1Department of Biotechnology and Bioengineering, Institute of Advanced Research (IAR), Gandhinagar, Gujarat, India.
Drug repurposing offers a novel strategy to advance cancer therapeutics by utilizing approved drugs. This approach, enhanced by new technologies and combination therapies, aims to improve treatment efficacy against complex malignancies.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Background:
- Cancer therapeutics face challenges due to complex tumor biology and evolving treatment resistance.
- Drug repurposing presents a strategic paradigm shift in developing new cancer treatments.
Purpose of the Study:
- To comprehend the strategic deployment and historical evolution of drug repurposing in oncology.
- To explore advanced methodologies for accelerating drug repurposing in cancer therapy.
- To assess breakthroughs and combination therapies involving repurposed drugs for enhanced efficacy.
Main Methods:
- Review of historical drug repurposing strategies.
- Exploration of modern tools: high-throughput screening, omics technologies, and artificial intelligence (AI).
- Analysis of combination therapies involving repurposed drugs.
Main Results:
- Identification of breakthroughs expanding the repertoire of repurposed drug candidates in cancer.
- Assessment of major categories of repurposed drugs.
- Elucidation of combination therapies targeting heterogeneous cancer populations and overcoming resistance.
Conclusions:
- Drug repurposing, supported by advanced technologies and combinatorial approaches, holds significant potential to advance cancer therapeutics.
- This strategy offers a path towards personalized and synergistic treatments, addressing key challenges in oncology.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...